Previous close | 12,999.50 |
Open | 13,071.00 |
Bid | 13,003.50 x N/A |
Ask | 13,138.00 x N/A |
Day's range | 13,015.50 - 13,126.50 |
52-week range | 4,350.00 - 14,376.00 |
Volume | |
Avg. volume | 141 |
Market cap | 106.425T |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 20.85 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 333.39 (2.40%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
PHILADELPHIA, June 03, 2024--Jemperli trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced dMMR rectal cancer
PHILADELPHIA, June 02, 2024--Belantamab Mafodotin combo reduced the risk of disease progression or death by nearly 50% versus SOC combo in relapsed/refractory multiple myeloma